Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023184
Filing Date
2022-11-08
Accepted
2022-11-08 16:01:21
Documents
83
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bxrx-20220930.htm   iXBRL 10-Q 3292806
2 EX-31.1 bxrx-ex31_1.htm EX-31.1 12437
3 EX-31.2 bxrx-ex31_2.htm EX-31.2 12996
4 EX-32.1 bxrx-ex32_1.htm EX-32.1 10244
  Complete submission text file 0000950170-22-023184.txt   12669889

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bxrx-20220930_def.xml EX-101.DEF 275490
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bxrx-20220930.xsd EX-101.SCH 82179
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bxrx-20220930_pre.xml EX-101.PRE 454529
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bxrx-20220930_lab.xml EX-101.LAB 619841
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bxrx-20220930_cal.xml EX-101.CAL 57089
77 EXTRACTED XBRL INSTANCE DOCUMENT bxrx-20220930_htm.xml XML 2529060
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

EIN.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39101 | Film No.: 221368735
SIC: 8090 Services-Misc Health & Allied Services, NEC